Kanabo Group (LON:KNB) Trading Down 23.3% – What’s Next?

Kanabo Group Plc (LON:KNB) shares fell 23.3% during mid-day trading on Monday . The stock traded as low as GBX 0.92 ($0.01) and last traded at GBX 0.92 ($0.01). 1,566,646 shares were traded during mid-day trading, an increase of 244% from the average session volume of 454,771 shares. The stock had previously closed at GBX 1.20 ($0.02).

Kanabo Group Price Performance

The company has a debt-to-equity ratio of 3.49, a quick ratio of 24.36 and a current ratio of 2.78. The company has a 50-day moving average of GBX 1.17 and a 200-day moving average of GBX 1.39. The firm has a market capitalization of £6.70 million, a price-to-earnings ratio of -92.00 and a beta of 3.04.

Insider Activity at Kanabo Group

In other Kanabo Group news, insider Ian Mattioli acquired 150,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 27th. The stock was acquired at an average cost of GBX 1 ($0.01) per share, for a total transaction of £1,500 ($1,945.27). 37.01% of the stock is owned by insiders.

About Kanabo Group

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain.